Further mechanistic studies indicated that mangiferin inhibits MMP‐9 by the inhibition of the binding of NF‐κB and AP‐1 to MMP‐9 promoters to block glioma invasion and angiogenesis.113. This evidence concerns the gene NFKB1 and central nervous system cancer.